MaxCyte, Inc.’s Post

Looking forward to this Webinar hosted by BioSurfaces, LLC Disruptive technology can be as simple as utilizing innovations from adjacent industries to solve cell therapy challenges. When thinking 'outside of the box', check out what's in the box next-door :)

Successfully advancing a cell therapy comes with ample time & money sinks already. That’s why we’ve developed SnapLVV, a simple, transparent pricing model for LVV manufacturing to get your therapy to first-in-human studies fast and with your future in mind. SnapLVV is an off-the-shelf process that requires no time-consuming development work. We’ve completed the framework for the process and analytics, so you can plug into a platform that’s ready to work for you. It’s a snap to put SnapLVV to work. Learn how here: https://hubs.ly/Q02PP-ny0

Thermo Fisher Scientific has a blog! And our "Behind the Bench Staff" wrote a post about tackling the Challenges in CAR T Cell Therapy Manufacturing! Click here for the post👉 https://lnkd.in/gjcyFb-n What I like most about the post is a short 100sec clip that shows our instruments designed for cell therapy manufacturing working together. You can also watch it directly here: https://lnkd.in/ezgYysCX

Unlock the Power of Precision in Cell Therapy! How can machine learning elevate UV spectroscopy for more accurate detection in cell therapies? Discover how these cutting-edge tools are reshaping detection limits, refining processes, and enhancing treatment reliability. 💡 Ready to see the future of diagnostics? Dive into the article today and explore the breakthroughs making waves in cell therapy! Read now and redefine what’s possible 👉 https://bit.ly/3Yk5Sr4 #CellTherapyInnovation #MachineLearningInLabs #UVSpectroscopy

With only a few weeks to go until the 7th CAR-TCR Summit Europe, we caught up with Ali Mohamed, PhD, Senior Vice President of CMC and Immatics to gain some early insights! View the full interview now: https://ter.li/ni8c62 Discover Ali's thoughts on: 🚧 What are the major hurdles that remain in cell therapy manufacturing? 🚀 Why are next-gen advances so important in the cell therapy space? 🎢 How can platforms like this help address these challenges and accelerate next gen advances? #CARTCR

Deadline tomorrow 🚨 Share your groundbreaking findings on HCT & cell therapy toxicities with global experts at #ToxicitiesConference24. Topics include solid organ malignancies, machine learning, novel approaches to improve outcomes, among others. Learn more & submit by Sept. 8: https://ow.ly/KCFr50T735J

Hello Fellow Researchers, Did you know Ultroser™ G offers 5x the concentration of Fetal Calf Serum? With just 2% reconstituted Ultroser™ G, you get the equivalent of 10% Fetal Calf Serum. Discover how this cutting-edge solution can elevate your in vitro cell research. #invitro #cellbiology #substitute #fcs #media #cellculture #livecellanalysis

Today, we are excited that GC Therapeutics emerged from stealth to announce its Series A raise. At Pear VC, part of our thesis within life sciences revolves around transformative technologies enabling the next generation of emerging modalities. One such modality, induced pluripotent stem cell (iPSC)-derived therapies, holds great promise to address a broad range of diseases. However, challenges in manufacturing, namely, complex and lengthy differentiation protocols, poor yields, and batch-to-batch variability, have severely limited this potential. Long design-build-test-learn cycles further hinder the rapid, scalable engineering and optimization of these products. With this mindset, when we met Parastoo Khoshakhlagh, Ph.D. and Alex Ng, Ph.D., we were impressed with how they and their colleagues had leveraged the TFome™ platform, GCTx’s iPSC cellular programming technology developed in the lab of Prof. George Church at Harvard Medical School and the Wyss Institute at Harvard University, to quickly accelerate development of best-in-class iPSC-derived cell therapies. The team quickly demonstrated the ability to make multiple high value cell types of interest from iPSCs via a single step process, offering several-fold improvements in time and cost without compromising potency or quality. The internal therapeutic programs focus on areas of severe unmet need across gastrointestinal, neurological, and immunological diseases, and beyond the core pipeline, the platform offers multiple opportunities for partnering. For these reasons, we were thrilled to welcome GCTx to the Pear portfolio, and we look forward to working with Parastoo, Alex, Cory Smith, and George, as well as our fellow investors at Cormorant Asset Management, LP, Mubadala Capital, Andreessen Horowitz, Medical Excellence Capital, LLC, among others, to support the company in its mission.

“Ireland has a golden opportunity to build on existing scientific, biomanufacturing, and clinical strengths and create a unique ecosystem to rival other, more established centres in Europe. The question to be addressed is, ‘If not now, why?’” Leading cell therapy scientist, Professor Sakis Mantalaris discusses Ireland's future standing in the industry of cell therapy in The Irish Independent. Sakis’ own work, being undertaken by Trinity College Dublin and NIBRT National Institute for Bioprocessing Research and Training in conjunction with Research Ireland, focuses on developing precision biomanufacturing strategies to generate high-quality cellular therapy products. The aim is to improve cell therapies with better qualities that may lead to better outcomes for patients. Read here:https://lnkd.in/esyF45Sj #ScienceWeek #IrishResearch

🆕 New Product Alert!! Want to step-up your cell culturing game? 🔬   Thermo Fisher Scientific has a new advanced cell culture surface that will help you do just that. Introducing the Nunclon Supra surface with proven compatibility on ~40 cells & cell lines, including harder-to-culture primary cells and MSCs for cell therapy research. The innovative treatment allows for xeno-free and low-serum applications. See how Supra surfaces improve cell yield, morphology and reduce cell adhesion time with no extra steps for coating prior to seeding.   Learn more about Nunclon Supra surfaces at: https://lnkd.in/ewfgZzyk where you can:   See our recent Webinar on culturing MSCs Read our how-to guide on how to create serum-free cultures of MSCs for cell therapy research applications Review our cell line performance data for compatibility And order your Supra surfaces today   #celltherapy #serumfree #cellculture #primarycells